Welcome to CDC stacks | NIH Consensus Development Conference statement on management of hepatitis B - 11556 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
NIH Consensus Development Conference statement on management of hepatitis B
Filetype[PDF-10.99 MB]


This document cannot be previewed automatically as it exceeds 5 MB
Please click the thumbnail image to view the document.
NIH Consensus Development Conference statement on management of hepatitis B
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Record of the proceedings : CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, November 17-18, 2008, Bethesda, Maryland
    Corporate Author:
    United States. Department of Health and Human Services.. Centers for Disease Control and Prevention (U.S.). United States. Health Resources and Services Administration..
    Published:
    2008
    Description:
    The Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and Health Resources and Services Administration (HRSA) convened a meeting of the CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment...
    File Type:
    Filetype[PDF - 313.63 KB]
  2. Record of the proceedings : Advisory Council for the Elimination of Tuberculosis, October 7-8, 2008, Atlanta, Georgia
    Corporate Author:
    Advisory Council for the Elimination of Tuberculosis (U.S.). Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Tuberculosis Elimination..
    Published:
    2008
    Description:
    The Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP) Division of Tuberculosis Elimination (DTBE) convened a meeting o...
    File Type:
    Filetype[PDF - 417.19 KB]
  3. A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study
    Personal Author:
    Southern, William N.; Norton, Brianna; Steinman, Meredith; DeLuca, Joseph; Drainoni, Mari-Lynn; Smith, Bryce D.; Litwin, Alain H.;
    Published:
    Dec 01 2015
    Source:
    BMC Infect Dis. 15.
    Description:
    Background : International guidelines and U.S. guidelines prior to 2012 only recommended testing for hepatitis C virus (HCV) infection among patients at risk, but adherence to guidelines is poor, and the majority of those infected remain undiagnosed....
    File Type:
    Filetype[PDF - 600.05 KB]
  4. A comprehensive approach; preventing blood-borne infections among injection drug users
    Corporate Author:
    Academy for Educational Development. National Center for HIV, STD, and TB Prevention (U.S.), Division of HIV/AIDS Prevention..
    Published:
    December 2000
    Description:
    NPIN 25665: This monograph provides a comprehensive approach to addressing the injection drug user's (IDU's) role in the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic and recommends strategies for community gro...
    File Type:
    Filetype[PDF - 2.48 MB]
  5. Medical management of chronic hepatitis B and chronic hepatitis C
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). Academy for Educational Development. Center on AIDS & Community Health..
    Published:
    September 2002
    Series:
    IDU/HIV prevention
    Description:
    Many individuals who become infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) develop chronic liver disease that can gradually lead to serious liver damage. Medical management involves periodic monitoring, abstinence from alcoholic bev...
    File Type:
    Filetype[PDF - 74.57 KB]